nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—migraine—Prednisone—multiple sclerosis	0.687	1	CpDpCtD
Naratriptan—HTR1B—trigeminal nucleus—multiple sclerosis	0.0273	0.219	CbGeAlD
Naratriptan—HTR1D—trigeminal nucleus—multiple sclerosis	0.0265	0.212	CbGeAlD
Naratriptan—HTR1D—meninx—multiple sclerosis	0.0176	0.14	CbGeAlD
Naratriptan—HTR1F—trigeminal nerve—multiple sclerosis	0.0175	0.14	CbGeAlD
Naratriptan—HTR1B—trigeminal nerve—multiple sclerosis	0.00718	0.0574	CbGeAlD
Naratriptan—HTR1D—trigeminal nerve—multiple sclerosis	0.00695	0.0556	CbGeAlD
Naratriptan—MAOA—nerve—multiple sclerosis	0.00193	0.0155	CbGeAlD
Naratriptan—HTR1F—nervous system—multiple sclerosis	0.00144	0.0115	CbGeAlD
Naratriptan—HTR1F—central nervous system—multiple sclerosis	0.00139	0.0111	CbGeAlD
Naratriptan—HTR1B—brainstem—multiple sclerosis	0.00113	0.009	CbGeAlD
Naratriptan—HTR1F—brain—multiple sclerosis	0.0011	0.0088	CbGeAlD
Naratriptan—HTR1D—brainstem—multiple sclerosis	0.00109	0.00871	CbGeAlD
Naratriptan—HTR1A—brainstem—multiple sclerosis	0.000908	0.00726	CbGeAlD
Naratriptan—MAOA—brainstem—multiple sclerosis	0.00083	0.00664	CbGeAlD
Naratriptan—MAOA—retina—multiple sclerosis	0.0008	0.0064	CbGeAlD
Naratriptan—HTR1B—midbrain—multiple sclerosis	0.000717	0.00574	CbGeAlD
Naratriptan—HTR1B—spinal cord—multiple sclerosis	0.0007	0.0056	CbGeAlD
Naratriptan—HTR1D—midbrain—multiple sclerosis	0.000694	0.00555	CbGeAlD
Naratriptan—HTR1B—nervous system—multiple sclerosis	0.00059	0.00472	CbGeAlD
Naratriptan—HTR1A—midbrain—multiple sclerosis	0.000579	0.00463	CbGeAlD
Naratriptan—MAOA—medulla oblongata—multiple sclerosis	0.000578	0.00463	CbGeAlD
Naratriptan—HTR1D—nervous system—multiple sclerosis	0.000571	0.00457	CbGeAlD
Naratriptan—HTR1B—central nervous system—multiple sclerosis	0.000568	0.00454	CbGeAlD
Naratriptan—HTR1A—spinal cord—multiple sclerosis	0.000565	0.00452	CbGeAlD
Naratriptan—HTR1D—central nervous system—multiple sclerosis	0.000549	0.0044	CbGeAlD
Naratriptan—MAOA—midbrain—multiple sclerosis	0.000529	0.00423	CbGeAlD
Naratriptan—MAOA—spinal cord—multiple sclerosis	0.000516	0.00413	CbGeAlD
Naratriptan—HTR1A—nervous system—multiple sclerosis	0.000476	0.00381	CbGeAlD
Naratriptan—HTR1A—central nervous system—multiple sclerosis	0.000458	0.00366	CbGeAlD
Naratriptan—HTR1B—brain—multiple sclerosis	0.000451	0.0036	CbGeAlD
Naratriptan—HTR1A—cerebellum—multiple sclerosis	0.000448	0.00358	CbGeAlD
Naratriptan—HTR1D—brain—multiple sclerosis	0.000436	0.00349	CbGeAlD
Naratriptan—MAOA—nervous system—multiple sclerosis	0.000435	0.00348	CbGeAlD
Naratriptan—MAOA—central nervous system—multiple sclerosis	0.000418	0.00335	CbGeAlD
Naratriptan—MAOA—cerebellum—multiple sclerosis	0.000409	0.00327	CbGeAlD
Naratriptan—HTR1A—brain—multiple sclerosis	0.000364	0.00291	CbGeAlD
Naratriptan—MAOA—brain—multiple sclerosis	0.000332	0.00266	CbGeAlD
Naratriptan—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000137	0.000946	CcSEcCtD
Naratriptan—Oedema—Prednisolone—multiple sclerosis	0.000136	0.000941	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000136	0.000941	CcSEcCtD
Naratriptan—Dizziness—Azathioprine—multiple sclerosis	0.000136	0.000939	CcSEcCtD
Naratriptan—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000135	0.000932	CcSEcCtD
Naratriptan—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000134	0.00093	CcSEcCtD
Naratriptan—Shock—Prednisolone—multiple sclerosis	0.000134	0.000926	CcSEcCtD
Naratriptan—Cough—Triamcinolone—multiple sclerosis	0.000134	0.000926	CcSEcCtD
Naratriptan—Convulsion—Triamcinolone—multiple sclerosis	0.000133	0.000919	CcSEcCtD
Naratriptan—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000133	0.000918	CcSEcCtD
Naratriptan—Convulsion—Methylprednisolone—multiple sclerosis	0.000133	0.000917	CcSEcCtD
Naratriptan—Urticaria—Mitoxantrone—multiple sclerosis	0.000132	0.000912	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000132	0.00091	CcSEcCtD
Naratriptan—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000131	0.000907	CcSEcCtD
Naratriptan—Myalgia—Triamcinolone—multiple sclerosis	0.000131	0.000903	CcSEcCtD
Naratriptan—Vomiting—Azathioprine—multiple sclerosis	0.00013	0.000903	CcSEcCtD
Naratriptan—Pneumonia—Methotrexate—multiple sclerosis	0.00013	0.000902	CcSEcCtD
Naratriptan—Arthralgia—Methylprednisolone—multiple sclerosis	0.00013	0.000901	CcSEcCtD
Naratriptan—Myalgia—Methylprednisolone—multiple sclerosis	0.00013	0.000901	CcSEcCtD
Naratriptan—Anxiety—Methylprednisolone—multiple sclerosis	0.00013	0.000898	CcSEcCtD
Naratriptan—Drowsiness—Methotrexate—multiple sclerosis	0.00013	0.000896	CcSEcCtD
Naratriptan—Rash—Azathioprine—multiple sclerosis	0.000129	0.000895	CcSEcCtD
Naratriptan—Dermatitis—Azathioprine—multiple sclerosis	0.000129	0.000894	CcSEcCtD
Naratriptan—Depression—Methotrexate—multiple sclerosis	0.000129	0.000894	CcSEcCtD
Naratriptan—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000129	0.000893	CcSEcCtD
Naratriptan—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000129	0.000893	CcSEcCtD
Naratriptan—Discomfort—Triamcinolone—multiple sclerosis	0.000129	0.000892	CcSEcCtD
Naratriptan—Discomfort—Methylprednisolone—multiple sclerosis	0.000129	0.00089	CcSEcCtD
Naratriptan—Headache—Azathioprine—multiple sclerosis	0.000129	0.000889	CcSEcCtD
Naratriptan—Dry mouth—Triamcinolone—multiple sclerosis	0.000128	0.000883	CcSEcCtD
Naratriptan—Angiopathy—Prednisone—multiple sclerosis	0.000126	0.000874	CcSEcCtD
Naratriptan—Confusional state—Methylprednisolone—multiple sclerosis	0.000126	0.000871	CcSEcCtD
Naratriptan—Immune system disorder—Prednisone—multiple sclerosis	0.000126	0.00087	CcSEcCtD
Naratriptan—Malaise—Dexamethasone—multiple sclerosis	0.000125	0.000868	CcSEcCtD
Naratriptan—Malaise—Betamethasone—multiple sclerosis	0.000125	0.000868	CcSEcCtD
Naratriptan—Oedema—Triamcinolone—multiple sclerosis	0.000125	0.000866	CcSEcCtD
Naratriptan—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000125	0.000866	CcSEcCtD
Naratriptan—Vertigo—Dexamethasone—multiple sclerosis	0.000125	0.000865	CcSEcCtD
Naratriptan—Vertigo—Betamethasone—multiple sclerosis	0.000125	0.000865	CcSEcCtD
Naratriptan—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000125	0.000864	CcSEcCtD
Naratriptan—Syncope—Dexamethasone—multiple sclerosis	0.000125	0.000863	CcSEcCtD
Naratriptan—Syncope—Betamethasone—multiple sclerosis	0.000125	0.000863	CcSEcCtD
Naratriptan—Arrhythmia—Prednisone—multiple sclerosis	0.000124	0.00086	CcSEcCtD
Naratriptan—Infection—Triamcinolone—multiple sclerosis	0.000124	0.00086	CcSEcCtD
Naratriptan—Sweating—Methotrexate—multiple sclerosis	0.000124	0.000859	CcSEcCtD
Naratriptan—Infection—Methylprednisolone—multiple sclerosis	0.000124	0.000858	CcSEcCtD
Naratriptan—Shock—Triamcinolone—multiple sclerosis	0.000123	0.000852	CcSEcCtD
Naratriptan—Alopecia—Prednisone—multiple sclerosis	0.000123	0.000851	CcSEcCtD
Naratriptan—Shock—Methylprednisolone—multiple sclerosis	0.000123	0.00085	CcSEcCtD
Naratriptan—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000122	0.000847	CcSEcCtD
Naratriptan—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000122	0.000846	CcSEcCtD
Naratriptan—Loss of consciousness—Betamethasone—multiple sclerosis	0.000122	0.000846	CcSEcCtD
Naratriptan—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000122	0.000845	CcSEcCtD
Naratriptan—Paraesthesia—Prednisolone—multiple sclerosis	0.000122	0.000845	CcSEcCtD
Naratriptan—Nausea—Azathioprine—multiple sclerosis	0.000122	0.000843	CcSEcCtD
Naratriptan—Skin disorder—Methylprednisolone—multiple sclerosis	0.000121	0.000839	CcSEcCtD
Naratriptan—Erythema—Prednisone—multiple sclerosis	0.000121	0.000838	CcSEcCtD
Naratriptan—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000121	0.000837	CcSEcCtD
Naratriptan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000121	0.000835	CcSEcCtD
Naratriptan—Convulsion—Betamethasone—multiple sclerosis	0.000121	0.000834	CcSEcCtD
Naratriptan—Convulsion—Dexamethasone—multiple sclerosis	0.000121	0.000834	CcSEcCtD
Naratriptan—Asthenia—Mitoxantrone—multiple sclerosis	0.000119	0.000823	CcSEcCtD
Naratriptan—Myalgia—Dexamethasone—multiple sclerosis	0.000118	0.000819	CcSEcCtD
Naratriptan—Myalgia—Betamethasone—multiple sclerosis	0.000118	0.000819	CcSEcCtD
Naratriptan—Anxiety—Betamethasone—multiple sclerosis	0.000118	0.000817	CcSEcCtD
Naratriptan—Anxiety—Dexamethasone—multiple sclerosis	0.000118	0.000817	CcSEcCtD
Naratriptan—Discomfort—Dexamethasone—multiple sclerosis	0.000117	0.00081	CcSEcCtD
Naratriptan—Discomfort—Betamethasone—multiple sclerosis	0.000117	0.00081	CcSEcCtD
Naratriptan—Haemoglobin—Methotrexate—multiple sclerosis	0.000117	0.000809	CcSEcCtD
Naratriptan—Hypotension—Methylprednisolone—multiple sclerosis	0.000117	0.000807	CcSEcCtD
Naratriptan—Pain—Prednisolone—multiple sclerosis	0.000116	0.000805	CcSEcCtD
Naratriptan—Haemorrhage—Methotrexate—multiple sclerosis	0.000116	0.000805	CcSEcCtD
Naratriptan—Vision blurred—Prednisone—multiple sclerosis	0.000114	0.00079	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000114	0.000789	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000114	0.000787	CcSEcCtD
Naratriptan—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000114	0.000786	CcSEcCtD
Naratriptan—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000114	0.000786	CcSEcCtD
Naratriptan—Oedema—Dexamethasone—multiple sclerosis	0.000114	0.000786	CcSEcCtD
Naratriptan—Oedema—Betamethasone—multiple sclerosis	0.000114	0.000786	CcSEcCtD
Naratriptan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000113	0.000785	CcSEcCtD
Naratriptan—Infection—Dexamethasone—multiple sclerosis	0.000113	0.00078	CcSEcCtD
Naratriptan—Infection—Betamethasone—multiple sclerosis	0.000113	0.00078	CcSEcCtD
Naratriptan—Ill-defined disorder—Prednisone—multiple sclerosis	0.000112	0.000778	CcSEcCtD
Naratriptan—Paraesthesia—Triamcinolone—multiple sclerosis	0.000112	0.000777	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisolone—multiple sclerosis	0.000112	0.000776	CcSEcCtD
Naratriptan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000112	0.000776	CcSEcCtD
Naratriptan—Anaemia—Prednisone—multiple sclerosis	0.000112	0.000775	CcSEcCtD
Naratriptan—Shock—Betamethasone—multiple sclerosis	0.000112	0.000773	CcSEcCtD
Naratriptan—Shock—Dexamethasone—multiple sclerosis	0.000112	0.000773	CcSEcCtD
Naratriptan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000112	0.000772	CcSEcCtD
Naratriptan—Nervous system disorder—Betamethasone—multiple sclerosis	0.000111	0.00077	CcSEcCtD
Naratriptan—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000111	0.00077	CcSEcCtD
Naratriptan—Agitation—Prednisone—multiple sclerosis	0.000111	0.00077	CcSEcCtD
Naratriptan—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000111	0.000769	CcSEcCtD
Naratriptan—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000111	0.000769	CcSEcCtD
Naratriptan—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00011	0.000759	CcSEcCtD
Naratriptan—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00011	0.000759	CcSEcCtD
Naratriptan—Malaise—Prednisone—multiple sclerosis	0.000109	0.000756	CcSEcCtD
Naratriptan—Vertigo—Prednisone—multiple sclerosis	0.000109	0.000753	CcSEcCtD
Naratriptan—Syncope—Prednisone—multiple sclerosis	0.000109	0.000752	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—multiple sclerosis	0.000108	0.00075	CcSEcCtD
Naratriptan—Urticaria—Prednisolone—multiple sclerosis	0.000108	0.000748	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—multiple sclerosis	0.000108	0.000747	CcSEcCtD
Naratriptan—Fatigue—Triamcinolone—multiple sclerosis	0.000108	0.000746	CcSEcCtD
Naratriptan—Fatigue—Methylprednisolone—multiple sclerosis	0.000108	0.000745	CcSEcCtD
Naratriptan—Pain—Triamcinolone—multiple sclerosis	0.000107	0.00074	CcSEcCtD
Naratriptan—Loss of consciousness—Prednisone—multiple sclerosis	0.000106	0.000737	CcSEcCtD
Naratriptan—Hypotension—Dexamethasone—multiple sclerosis	0.000106	0.000734	CcSEcCtD
Naratriptan—Hypotension—Betamethasone—multiple sclerosis	0.000106	0.000734	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—multiple sclerosis	0.000106	0.00073	CcSEcCtD
Naratriptan—Vomiting—Mitoxantrone—multiple sclerosis	0.000105	0.00073	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—multiple sclerosis	0.000105	0.000727	CcSEcCtD
Naratriptan—Convulsion—Prednisone—multiple sclerosis	0.000105	0.000726	CcSEcCtD
Naratriptan—Rash—Mitoxantrone—multiple sclerosis	0.000105	0.000724	CcSEcCtD
Naratriptan—Dermatitis—Mitoxantrone—multiple sclerosis	0.000104	0.000723	CcSEcCtD
Naratriptan—Chills—Methotrexate—multiple sclerosis	0.000104	0.000722	CcSEcCtD
Naratriptan—Headache—Mitoxantrone—multiple sclerosis	0.000104	0.000719	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000103	0.000716	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000103	0.000716	CcSEcCtD
Naratriptan—Arthralgia—Prednisone—multiple sclerosis	0.000103	0.000714	CcSEcCtD
Naratriptan—Myalgia—Prednisone—multiple sclerosis	0.000103	0.000714	CcSEcCtD
Naratriptan—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000103	0.000713	CcSEcCtD
Naratriptan—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000103	0.000712	CcSEcCtD
Naratriptan—Anxiety—Prednisone—multiple sclerosis	0.000103	0.000711	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—multiple sclerosis	0.000103	0.000711	CcSEcCtD
Naratriptan—Paraesthesia—Dexamethasone—multiple sclerosis	0.000102	0.000705	CcSEcCtD
Naratriptan—Paraesthesia—Betamethasone—multiple sclerosis	0.000102	0.000705	CcSEcCtD
Naratriptan—Discomfort—Prednisone—multiple sclerosis	0.000102	0.000705	CcSEcCtD
Naratriptan—Erythema—Methotrexate—multiple sclerosis	0.000101	0.000701	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisolone—multiple sclerosis	0.0001	0.000694	CcSEcCtD
Naratriptan—Urticaria—Triamcinolone—multiple sclerosis	9.94e-05	0.000688	CcSEcCtD
Naratriptan—Urticaria—Methylprednisolone—multiple sclerosis	9.92e-05	0.000686	CcSEcCtD
Naratriptan—Body temperature increased—Triamcinolone—multiple sclerosis	9.89e-05	0.000684	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisone—multiple sclerosis	9.89e-05	0.000684	CcSEcCtD
Naratriptan—Oedema—Prednisone—multiple sclerosis	9.89e-05	0.000684	CcSEcCtD
Naratriptan—Nausea—Mitoxantrone—multiple sclerosis	9.85e-05	0.000682	CcSEcCtD
Naratriptan—Infection—Prednisone—multiple sclerosis	9.82e-05	0.00068	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	9.8e-05	0.000678	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	9.8e-05	0.000678	CcSEcCtD
Naratriptan—Fatigue—Dexamethasone—multiple sclerosis	9.79e-05	0.000677	CcSEcCtD
Naratriptan—Fatigue—Betamethasone—multiple sclerosis	9.79e-05	0.000677	CcSEcCtD
Naratriptan—Shock—Prednisone—multiple sclerosis	9.73e-05	0.000673	CcSEcCtD
Naratriptan—Pain—Betamethasone—multiple sclerosis	9.71e-05	0.000672	CcSEcCtD
Naratriptan—Pain—Dexamethasone—multiple sclerosis	9.71e-05	0.000672	CcSEcCtD
Naratriptan—Nervous system disorder—Prednisone—multiple sclerosis	9.7e-05	0.000671	CcSEcCtD
Naratriptan—Skin disorder—Prednisone—multiple sclerosis	9.6e-05	0.000664	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisone—multiple sclerosis	9.56e-05	0.000661	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—multiple sclerosis	9.54e-05	0.00066	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—multiple sclerosis	9.39e-05	0.00065	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—multiple sclerosis	9.36e-05	0.000647	CcSEcCtD
Naratriptan—Feeling abnormal—Dexamethasone—multiple sclerosis	9.36e-05	0.000647	CcSEcCtD
Naratriptan—Feeling abnormal—Betamethasone—multiple sclerosis	9.36e-05	0.000647	CcSEcCtD
Naratriptan—Hypersensitivity—Triamcinolone—multiple sclerosis	9.22e-05	0.000638	CcSEcCtD
Naratriptan—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.2e-05	0.000636	CcSEcCtD
Naratriptan—Malaise—Methotrexate—multiple sclerosis	9.13e-05	0.000632	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—multiple sclerosis	9.1e-05	0.000629	CcSEcCtD
Naratriptan—Urticaria—Dexamethasone—multiple sclerosis	9.02e-05	0.000624	CcSEcCtD
Naratriptan—Urticaria—Betamethasone—multiple sclerosis	9.02e-05	0.000624	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.01e-05	0.000623	CcSEcCtD
Naratriptan—Dizziness—Prednisolone—multiple sclerosis	9e-05	0.000623	CcSEcCtD
Naratriptan—Asthenia—Triamcinolone—multiple sclerosis	8.98e-05	0.000621	CcSEcCtD
Naratriptan—Body temperature increased—Dexamethasone—multiple sclerosis	8.98e-05	0.000621	CcSEcCtD
Naratriptan—Body temperature increased—Betamethasone—multiple sclerosis	8.98e-05	0.000621	CcSEcCtD
Naratriptan—Asthenia—Methylprednisolone—multiple sclerosis	8.96e-05	0.00062	CcSEcCtD
Naratriptan—Paraesthesia—Prednisone—multiple sclerosis	8.88e-05	0.000614	CcSEcCtD
Naratriptan—Pruritus—Triamcinolone—multiple sclerosis	8.85e-05	0.000613	CcSEcCtD
Naratriptan—Cough—Methotrexate—multiple sclerosis	8.84e-05	0.000611	CcSEcCtD
Naratriptan—Pruritus—Methylprednisolone—multiple sclerosis	8.83e-05	0.000611	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—multiple sclerosis	8.77e-05	0.000607	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—multiple sclerosis	8.62e-05	0.000596	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—multiple sclerosis	8.62e-05	0.000596	CcSEcCtD
Naratriptan—Rash—Prednisolone—multiple sclerosis	8.58e-05	0.000594	CcSEcCtD
Naratriptan—Dermatitis—Prednisolone—multiple sclerosis	8.57e-05	0.000593	CcSEcCtD
Naratriptan—Diarrhoea—Methylprednisolone—multiple sclerosis	8.54e-05	0.000591	CcSEcCtD
Naratriptan—Fatigue—Prednisone—multiple sclerosis	8.53e-05	0.00059	CcSEcCtD
Naratriptan—Headache—Prednisolone—multiple sclerosis	8.52e-05	0.00059	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—multiple sclerosis	8.52e-05	0.000589	CcSEcCtD
Naratriptan—Constipation—Prednisone—multiple sclerosis	8.46e-05	0.000585	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—multiple sclerosis	8.33e-05	0.000576	CcSEcCtD
Naratriptan—Dizziness—Triamcinolone—multiple sclerosis	8.27e-05	0.000572	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—multiple sclerosis	8.26e-05	0.000572	CcSEcCtD
Naratriptan—Dizziness—Methylprednisolone—multiple sclerosis	8.26e-05	0.000571	CcSEcCtD
Naratriptan—Infection—Methotrexate—multiple sclerosis	8.21e-05	0.000568	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisone—multiple sclerosis	8.15e-05	0.000564	CcSEcCtD
Naratriptan—Asthenia—Dexamethasone—multiple sclerosis	8.15e-05	0.000564	CcSEcCtD
Naratriptan—Asthenia—Betamethasone—multiple sclerosis	8.15e-05	0.000564	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—multiple sclerosis	8.1e-05	0.000561	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—multiple sclerosis	8.09e-05	0.00056	CcSEcCtD
Naratriptan—Nausea—Prednisolone—multiple sclerosis	8.08e-05	0.000559	CcSEcCtD
Naratriptan—Pruritus—Betamethasone—multiple sclerosis	8.03e-05	0.000556	CcSEcCtD
Naratriptan—Pruritus—Dexamethasone—multiple sclerosis	8.03e-05	0.000556	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—multiple sclerosis	8.03e-05	0.000555	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—multiple sclerosis	7.99e-05	0.000553	CcSEcCtD
Naratriptan—Vomiting—Triamcinolone—multiple sclerosis	7.96e-05	0.00055	CcSEcCtD
Naratriptan—Vomiting—Methylprednisolone—multiple sclerosis	7.94e-05	0.000549	CcSEcCtD
Naratriptan—Rash—Triamcinolone—multiple sclerosis	7.89e-05	0.000546	CcSEcCtD
Naratriptan—Dermatitis—Triamcinolone—multiple sclerosis	7.88e-05	0.000545	CcSEcCtD
Naratriptan—Rash—Methylprednisolone—multiple sclerosis	7.87e-05	0.000545	CcSEcCtD
Naratriptan—Dermatitis—Methylprednisolone—multiple sclerosis	7.87e-05	0.000544	CcSEcCtD
Naratriptan—Urticaria—Prednisone—multiple sclerosis	7.86e-05	0.000543	CcSEcCtD
Naratriptan—Headache—Triamcinolone—multiple sclerosis	7.84e-05	0.000542	CcSEcCtD
Naratriptan—Headache—Methylprednisolone—multiple sclerosis	7.82e-05	0.000541	CcSEcCtD
Naratriptan—Body temperature increased—Prednisone—multiple sclerosis	7.82e-05	0.000541	CcSEcCtD
Naratriptan—Diarrhoea—Dexamethasone—multiple sclerosis	7.77e-05	0.000537	CcSEcCtD
Naratriptan—Diarrhoea—Betamethasone—multiple sclerosis	7.77e-05	0.000537	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—multiple sclerosis	7.72e-05	0.000534	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.53e-05	0.000521	CcSEcCtD
Naratriptan—Dizziness—Dexamethasone—multiple sclerosis	7.51e-05	0.000519	CcSEcCtD
Naratriptan—Dizziness—Betamethasone—multiple sclerosis	7.51e-05	0.000519	CcSEcCtD
Naratriptan—Nausea—Triamcinolone—multiple sclerosis	7.43e-05	0.000514	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—multiple sclerosis	7.42e-05	0.000513	CcSEcCtD
Naratriptan—Nausea—Methylprednisolone—multiple sclerosis	7.42e-05	0.000513	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—multiple sclerosis	7.37e-05	0.00051	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—multiple sclerosis	7.35e-05	0.000508	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisone—multiple sclerosis	7.29e-05	0.000504	CcSEcCtD
Naratriptan—Vomiting—Dexamethasone—multiple sclerosis	7.22e-05	0.000499	CcSEcCtD
Naratriptan—Vomiting—Betamethasone—multiple sclerosis	7.22e-05	0.000499	CcSEcCtD
Naratriptan—Rash—Betamethasone—multiple sclerosis	7.16e-05	0.000495	CcSEcCtD
Naratriptan—Rash—Dexamethasone—multiple sclerosis	7.16e-05	0.000495	CcSEcCtD
Naratriptan—Dermatitis—Betamethasone—multiple sclerosis	7.15e-05	0.000495	CcSEcCtD
Naratriptan—Dermatitis—Dexamethasone—multiple sclerosis	7.15e-05	0.000495	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	7.13e-05	0.000494	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—multiple sclerosis	7.12e-05	0.000493	CcSEcCtD
Naratriptan—Headache—Dexamethasone—multiple sclerosis	7.11e-05	0.000492	CcSEcCtD
Naratriptan—Headache—Betamethasone—multiple sclerosis	7.11e-05	0.000492	CcSEcCtD
Naratriptan—Asthenia—Prednisone—multiple sclerosis	7.09e-05	0.000491	CcSEcCtD
Naratriptan—Pain—Methotrexate—multiple sclerosis	7.07e-05	0.000489	CcSEcCtD
Naratriptan—Pruritus—Prednisone—multiple sclerosis	7e-05	0.000484	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—multiple sclerosis	6.81e-05	0.000471	CcSEcCtD
Naratriptan—Diarrhoea—Prednisone—multiple sclerosis	6.77e-05	0.000468	CcSEcCtD
Naratriptan—Nausea—Betamethasone—multiple sclerosis	6.74e-05	0.000467	CcSEcCtD
Naratriptan—Nausea—Dexamethasone—multiple sclerosis	6.74e-05	0.000467	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—multiple sclerosis	6.56e-05	0.000454	CcSEcCtD
Naratriptan—Dizziness—Prednisone—multiple sclerosis	6.54e-05	0.000452	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—multiple sclerosis	6.53e-05	0.000452	CcSEcCtD
Naratriptan—Vomiting—Prednisone—multiple sclerosis	6.29e-05	0.000435	CcSEcCtD
Naratriptan—Rash—Prednisone—multiple sclerosis	6.23e-05	0.000431	CcSEcCtD
Naratriptan—Dermatitis—Prednisone—multiple sclerosis	6.23e-05	0.000431	CcSEcCtD
Naratriptan—Headache—Prednisone—multiple sclerosis	6.19e-05	0.000429	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—multiple sclerosis	6.09e-05	0.000421	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—multiple sclerosis	5.93e-05	0.00041	CcSEcCtD
Naratriptan—Nausea—Prednisone—multiple sclerosis	5.87e-05	0.000406	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—multiple sclerosis	5.85e-05	0.000404	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—multiple sclerosis	5.65e-05	0.000391	CcSEcCtD
Naratriptan—HTR1B—GPCR ligand binding—CCL5—multiple sclerosis	5.58e-05	0.00127	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CNR1—multiple sclerosis	5.48e-05	0.00125	CbGpPWpGaD
Naratriptan—Dizziness—Methotrexate—multiple sclerosis	5.46e-05	0.000378	CcSEcCtD
Naratriptan—HTR1A—Signaling by GPCR—RGS1—multiple sclerosis	5.46e-05	0.00124	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CXCL10—multiple sclerosis	5.31e-05	0.00121	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.27e-05	0.0012	CbGpPWpGaD
Naratriptan—Vomiting—Methotrexate—multiple sclerosis	5.25e-05	0.000364	CcSEcCtD
Naratriptan—Rash—Methotrexate—multiple sclerosis	5.21e-05	0.00036	CcSEcCtD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL13—multiple sclerosis	5.21e-05	0.00119	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR1—multiple sclerosis	5.21e-05	0.00119	CbGpPWpGaD
Naratriptan—Dermatitis—Methotrexate—multiple sclerosis	5.21e-05	0.00036	CcSEcCtD
Naratriptan—MAOA—Metabolism—GPC5—multiple sclerosis	5.19e-05	0.00118	CbGpPWpGaD
Naratriptan—Headache—Methotrexate—multiple sclerosis	5.18e-05	0.000358	CcSEcCtD
Naratriptan—HTR1A—Signaling by GPCR—GPR65—multiple sclerosis	5.17e-05	0.00118	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.16e-05	0.00118	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.15e-05	0.00117	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CCR5—multiple sclerosis	5.13e-05	0.00117	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.09e-05	0.00116	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—S1PR1—multiple sclerosis	5.08e-05	0.00116	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.04e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CCL5—multiple sclerosis	5.03e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	5.03e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCR5—multiple sclerosis	5.02e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LINGO1—multiple sclerosis	5e-05	0.00114	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—S1PR1—multiple sclerosis	4.98e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GPC5—multiple sclerosis	4.94e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—POMC—multiple sclerosis	4.94e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CXCL10—multiple sclerosis	4.93e-05	0.00113	CbGpPWpGaD
Naratriptan—Nausea—Methotrexate—multiple sclerosis	4.91e-05	0.00034	CcSEcCtD
Naratriptan—HTR1B—Signaling Pathways—GPC5—multiple sclerosis	4.84e-05	0.0011	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PTGER4—multiple sclerosis	4.79e-05	0.00109	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR1—multiple sclerosis	4.73e-05	0.00108	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL13—multiple sclerosis	4.73e-05	0.00108	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PTGER4—multiple sclerosis	4.69e-05	0.00107	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCR3—multiple sclerosis	4.63e-05	0.00105	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCL5—multiple sclerosis	4.57e-05	0.00104	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CCR5—multiple sclerosis	4.53e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCR3—multiple sclerosis	4.53e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL3—multiple sclerosis	4.52e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCR2—multiple sclerosis	4.5e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—IL2RA—multiple sclerosis	4.47e-05	0.00102	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL3—multiple sclerosis	4.42e-05	0.00101	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCR2—multiple sclerosis	4.41e-05	0.001	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PTGER4—multiple sclerosis	4.35e-05	0.000992	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.34e-05	0.00099	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TAGAP—multiple sclerosis	4.34e-05	0.000989	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RGS1—multiple sclerosis	4.32e-05	0.000985	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—RRM1—multiple sclerosis	4.3e-05	0.00098	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PTGER4—multiple sclerosis	4.26e-05	0.000971	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCL5—multiple sclerosis	4.25e-05	0.000969	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RGS1—multiple sclerosis	4.23e-05	0.000964	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCR3—multiple sclerosis	4.2e-05	0.000958	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL3—multiple sclerosis	4.17e-05	0.000952	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CNR1—multiple sclerosis	4.15e-05	0.000947	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCR5—multiple sclerosis	4.12e-05	0.000939	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCR3—multiple sclerosis	4.11e-05	0.000938	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GPR65—multiple sclerosis	4.1e-05	0.000934	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCR2—multiple sclerosis	4.09e-05	0.000932	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CNR1—multiple sclerosis	4.07e-05	0.000927	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL2RA—multiple sclerosis	4.06e-05	0.000925	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTGER4—multiple sclerosis	4.02e-05	0.000916	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GPR65—multiple sclerosis	4.01e-05	0.000914	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—POMC—multiple sclerosis	4.01e-05	0.000914	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCR2—multiple sclerosis	4e-05	0.000912	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PGR—multiple sclerosis	3.96e-05	0.000902	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.93e-05	0.000896	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—POMC—multiple sclerosis	3.93e-05	0.000895	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CCL2—multiple sclerosis	3.92e-05	0.000895	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCR3—multiple sclerosis	3.88e-05	0.000885	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CD28—multiple sclerosis	3.84e-05	0.000876	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.84e-05	0.000876	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCL2—multiple sclerosis	3.84e-05	0.000876	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCR5—multiple sclerosis	3.83e-05	0.000873	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—S1PR1—multiple sclerosis	3.79e-05	0.000864	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCR2—multiple sclerosis	3.77e-05	0.000861	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CNR1—multiple sclerosis	3.77e-05	0.00086	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR1—multiple sclerosis	3.75e-05	0.000854	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL13—multiple sclerosis	3.75e-05	0.000854	CbGpPWpGaD
Naratriptan—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.74e-05	0.000853	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL10—multiple sclerosis	3.74e-05	0.000852	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CNR1—multiple sclerosis	3.69e-05	0.000842	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.69e-05	0.000842	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GPC5—multiple sclerosis	3.69e-05	0.000841	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR1—multiple sclerosis	3.67e-05	0.000836	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL13—multiple sclerosis	3.67e-05	0.000836	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL10—multiple sclerosis	3.66e-05	0.000835	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PTGER4—multiple sclerosis	3.57e-05	0.000815	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—POMC—multiple sclerosis	3.54e-05	0.000808	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.5e-05	0.000799	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CNR1—multiple sclerosis	3.48e-05	0.000794	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCR3—multiple sclerosis	3.45e-05	0.000787	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL10—multiple sclerosis	3.4e-05	0.000774	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL3—multiple sclerosis	3.37e-05	0.000768	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR2—multiple sclerosis	3.36e-05	0.000765	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL10—multiple sclerosis	3.32e-05	0.000758	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PTGER4—multiple sclerosis	3.24e-05	0.00074	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RGS1—multiple sclerosis	3.22e-05	0.000735	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCL5—multiple sclerosis	3.22e-05	0.000734	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—POMC—multiple sclerosis	3.22e-05	0.000734	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCL5—multiple sclerosis	3.15e-05	0.000719	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCL2—multiple sclerosis	3.15e-05	0.000718	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL10—multiple sclerosis	3.14e-05	0.000715	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCR3—multiple sclerosis	3.13e-05	0.000714	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CNR1—multiple sclerosis	3.1e-05	0.000706	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GPR65—multiple sclerosis	3.05e-05	0.000697	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR2—multiple sclerosis	3.05e-05	0.000695	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—POMC—multiple sclerosis	2.99e-05	0.000682	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.98e-05	0.000679	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCL2—multiple sclerosis	2.93e-05	0.000667	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL5—multiple sclerosis	2.92e-05	0.000666	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCR5—multiple sclerosis	2.9e-05	0.000661	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—MAPK1—multiple sclerosis	2.86e-05	0.000653	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL5—multiple sclerosis	2.86e-05	0.000652	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—TYK2—multiple sclerosis	2.86e-05	0.000652	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2RA—multiple sclerosis	2.86e-05	0.000652	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCR5—multiple sclerosis	2.84e-05	0.000647	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CNR1—multiple sclerosis	2.81e-05	0.000641	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2RA—multiple sclerosis	2.8e-05	0.000638	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL13—multiple sclerosis	2.79e-05	0.000637	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR1—multiple sclerosis	2.79e-05	0.000637	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	2.79e-05	0.000636	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CD86—multiple sclerosis	2.74e-05	0.000625	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL5—multiple sclerosis	2.7e-05	0.000616	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL3—multiple sclerosis	2.67e-05	0.000609	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCR5—multiple sclerosis	2.63e-05	0.0006	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—IL2—multiple sclerosis	2.62e-05	0.000597	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL3—multiple sclerosis	2.61e-05	0.000596	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2RA—multiple sclerosis	2.6e-05	0.000592	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCR5—multiple sclerosis	2.58e-05	0.000588	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTGER4—multiple sclerosis	2.57e-05	0.000586	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2RA—multiple sclerosis	2.54e-05	0.000579	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL10—multiple sclerosis	2.53e-05	0.000577	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PGR—multiple sclerosis	2.53e-05	0.000577	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTGER4—multiple sclerosis	2.52e-05	0.000574	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SPP1—multiple sclerosis	2.5e-05	0.00057	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCR3—multiple sclerosis	2.48e-05	0.000566	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PGR—multiple sclerosis	2.48e-05	0.000565	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—BCHE—multiple sclerosis	2.47e-05	0.000563	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CD28—multiple sclerosis	2.46e-05	0.00056	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCR5—multiple sclerosis	2.43e-05	0.000555	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCR3—multiple sclerosis	2.43e-05	0.000554	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR2—multiple sclerosis	2.41e-05	0.00055	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CD28—multiple sclerosis	2.41e-05	0.000549	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	2.4e-05	0.000547	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2RA—multiple sclerosis	2.4e-05	0.000547	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL2—multiple sclerosis	2.38e-05	0.000542	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR2—multiple sclerosis	2.36e-05	0.000539	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—POMC—multiple sclerosis	2.27e-05	0.000517	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CNR1—multiple sclerosis	2.23e-05	0.000508	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—POMC—multiple sclerosis	2.22e-05	0.000506	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APOE—multiple sclerosis	2.21e-05	0.000505	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CNR1—multiple sclerosis	2.18e-05	0.000497	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	2.18e-05	0.000497	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	2.16e-05	0.000493	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.13e-05	0.000486	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—POMC—multiple sclerosis	2.06e-05	0.000469	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—POMC—multiple sclerosis	2.01e-05	0.000459	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL2—multiple sclerosis	2.01e-05	0.000459	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL10—multiple sclerosis	2.01e-05	0.000457	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CD80—multiple sclerosis	2e-05	0.000456	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	1.99e-05	0.000454	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	1.97e-05	0.00045	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	1.96e-05	0.000448	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	1.96e-05	0.000448	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.94e-05	0.000441	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	1.92e-05	0.000437	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—POMC—multiple sclerosis	1.9e-05	0.000433	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PGR—multiple sclerosis	1.89e-05	0.00043	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL2—multiple sclerosis	1.86e-05	0.000424	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	1.85e-05	0.000422	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CD28—multiple sclerosis	1.83e-05	0.000418	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TYK2—multiple sclerosis	1.83e-05	0.000417	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—MAPK1—multiple sclerosis	1.82e-05	0.000415	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	1.8e-05	0.000411	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	1.79e-05	0.000408	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CD86—multiple sclerosis	1.75e-05	0.0004	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL5—multiple sclerosis	1.73e-05	0.000394	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CD86—multiple sclerosis	1.72e-05	0.000392	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	1.69e-05	0.000385	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	1.69e-05	0.000385	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TYK2—multiple sclerosis	1.69e-05	0.000385	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2—multiple sclerosis	1.68e-05	0.000382	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	1.66e-05	0.000379	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	1.64e-05	0.000374	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SPP1—multiple sclerosis	1.6e-05	0.000365	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	1.57e-05	0.000357	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR5—multiple sclerosis	1.56e-05	0.000355	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	1.53e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2RA—multiple sclerosis	1.53e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	1.52e-05	0.000347	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2—multiple sclerosis	1.52e-05	0.000347	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	1.5e-05	0.000342	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	1.5e-05	0.000342	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	1.5e-05	0.000341	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	1.49e-05	0.00034	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—multiple sclerosis	1.48e-05	0.000339	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—multiple sclerosis	1.42e-05	0.000323	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2—multiple sclerosis	1.41e-05	0.00032	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—multiple sclerosis	1.4e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—multiple sclerosis	1.39e-05	0.000316	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	1.36e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—multiple sclerosis	1.33e-05	0.000303	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CD86—multiple sclerosis	1.31e-05	0.000298	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	1.29e-05	0.000294	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CD80—multiple sclerosis	1.28e-05	0.000292	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—multiple sclerosis	1.28e-05	0.000291	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CD80—multiple sclerosis	1.25e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	1.25e-05	0.000285	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—multiple sclerosis	1.22e-05	0.000277	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	1.19e-05	0.000272	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—multiple sclerosis	1.19e-05	0.000271	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	1.19e-05	0.000271	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—multiple sclerosis	1.18e-05	0.00027	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	1.16e-05	0.000266	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.16e-05	0.000265	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—multiple sclerosis	1.16e-05	0.000265	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.16e-05	0.000265	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.14e-05	0.000261	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.14e-05	0.00026	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.13e-05	0.000259	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—multiple sclerosis	1.1e-05	0.000251	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—multiple sclerosis	1.1e-05	0.00025	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	1.08e-05	0.000246	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK1—multiple sclerosis	1.08e-05	0.000245	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	1.06e-05	0.000241	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.06e-05	0.000241	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CD80—multiple sclerosis	9.54e-06	0.000218	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—multiple sclerosis	9.07e-06	0.000207	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2—multiple sclerosis	8.99e-06	0.000205	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	8.94e-06	0.000204	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	8.87e-06	0.000202	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2—multiple sclerosis	8.8e-06	0.000201	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	8.76e-06	0.0002	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	8.68e-06	0.000198	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	8.51e-06	0.000194	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	8.33e-06	0.00019	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—multiple sclerosis	8.26e-06	0.000188	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	8.06e-06	0.000184	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	7.56e-06	0.000172	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	7.4e-06	0.000169	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—multiple sclerosis	7.03e-06	0.00016	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	7.01e-06	0.00016	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—multiple sclerosis	6.88e-06	0.000157	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	6.87e-06	0.000157	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	6.86e-06	0.000157	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	6.73e-06	0.000153	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2—multiple sclerosis	6.7e-06	0.000153	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	6.67e-06	0.000152	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	6.34e-06	0.000145	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	5.64e-06	0.000129	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—multiple sclerosis	5.28e-06	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—multiple sclerosis	5.24e-06	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	5.23e-06	0.000119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—multiple sclerosis	5.17e-06	0.000118	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	5.13e-06	0.000117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—multiple sclerosis	3.94e-06	8.98e-05	CbGpPWpGaD
